IE37292B1 - Mineral salt preparation - Google Patents
Mineral salt preparationInfo
- Publication number
- IE37292B1 IE37292B1 IE252/73A IE25273A IE37292B1 IE 37292 B1 IE37292 B1 IE 37292B1 IE 252/73 A IE252/73 A IE 252/73A IE 25273 A IE25273 A IE 25273A IE 37292 B1 IE37292 B1 IE 37292B1
- Authority
- IE
- Ireland
- Prior art keywords
- weight
- sodium
- parts
- magnesium
- salts
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 6
- 150000003839 salts Chemical class 0.000 title abstract 6
- 229910052500 inorganic mineral Inorganic materials 0.000 title abstract 4
- 239000011707 mineral Substances 0.000 title abstract 4
- 235000002639 sodium chloride Nutrition 0.000 abstract 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 4
- 239000011734 sodium Substances 0.000 abstract 4
- 229910052708 sodium Inorganic materials 0.000 abstract 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 3
- 239000011575 calcium Substances 0.000 abstract 3
- 229910052791 calcium Inorganic materials 0.000 abstract 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
- 235000010755 mineral Nutrition 0.000 abstract 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 2
- 239000011777 magnesium Substances 0.000 abstract 2
- 229910052749 magnesium Inorganic materials 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 101000653791 Bos taurus Protein S100-A12 Proteins 0.000 abstract 1
- 150000000994 L-ascorbates Chemical class 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical class [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000004359 castor oil Substances 0.000 abstract 1
- 235000019438 castor oil Nutrition 0.000 abstract 1
- 150000001860 citric acid derivatives Chemical class 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 239000002934 diuretic Substances 0.000 abstract 1
- 229940030606 diuretics Drugs 0.000 abstract 1
- 239000003792 electrolyte Substances 0.000 abstract 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 abstract 1
- 150000002315 glycerophosphates Chemical class 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- 235000001130 magnesium glycerophosphate Nutrition 0.000 abstract 1
- 235000021317 phosphate Nutrition 0.000 abstract 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 235000011164 potassium chloride Nutrition 0.000 abstract 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 abstract 1
- 229920002994 synthetic fiber Polymers 0.000 abstract 1
- 150000003892 tartrate salts Chemical class 0.000 abstract 1
- 230000005068 transpiration Effects 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH272072 | 1972-02-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE37292L IE37292L (en) | 1973-08-25 |
| IE37292B1 true IE37292B1 (en) | 1977-06-22 |
Family
ID=4240086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE252/73A IE37292B1 (en) | 1972-02-25 | 1973-02-19 | Mineral salt preparation |
Country Status (14)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI834309A7 (fi) * | 1983-11-24 | 1985-05-25 | Pharmaconsult Oy | Suolaseos. |
| US4954349A (en) * | 1987-09-11 | 1990-09-04 | Ciba-Geigy Corporation | Oral magnesium and potassium compositions and use |
| CH677612A5 (enrdf_load_html_response) * | 1987-09-11 | 1991-06-14 | Ciba Geigy Ag | |
| US5035898A (en) * | 1987-11-27 | 1991-07-30 | Schering Corporation | Potassium/magnesium supplement |
| FI120290B (fi) * | 1996-12-30 | 2009-09-15 | Mirador Res Oy Ltd | Menetelmä, jonka avulla voidaan valmistaa sellaisia mausteseos-, ruoan ainesosa- ja elintarvikekoostumuksia, jotka alentavat seerumin kolesterolia |
| FR2773955B1 (fr) * | 1998-01-26 | 2000-04-07 | Sanofi Sa | Composition dietetique sous forme d'un sel de substitution du sel de table |
| FR2931359B1 (fr) | 2008-05-20 | 2012-12-21 | Menvielle Bourg Fabienne Joanny | Utilisation d'une matrice pour administration orale de magnesium a liberation prolongee, et composition contenant cette matrice |
| FR2931361B1 (fr) | 2008-05-20 | 2012-08-31 | Menvielle Bourg Fabienne Joanny | Systeme a base de magnesium et son utilisation en cosmetique |
| EP2813217A1 (fr) | 2013-06-11 | 2014-12-17 | Fabienne Joanny Menvielle-Bourg | Composition pour administration orale de magnésium, en association avec une composition destinée à traiter le diabète de type 2 ou ses complications |
| FR3024019B1 (fr) * | 2014-07-28 | 2017-11-24 | Yvan Erbs | Complement alimentaire pour ameliorer le fonctionnement des cellules vivantes et procede associe |
| US20210196748A1 (en) | 2019-12-30 | 2021-07-01 | Robert Olson | Composition and therapy for treatment of gag reflexes |
-
1973
- 1973-01-22 ZA ZA730467A patent/ZA73467B/xx unknown
- 1973-01-25 AU AU51455/73A patent/AU451930B2/en not_active Expired
- 1973-01-25 IT IT19595/73A patent/IT978459B/it active
- 1973-01-29 IL IL41412A patent/IL41412A/en unknown
- 1973-02-07 DE DE2305980A patent/DE2305980A1/de not_active Withdrawn
- 1973-02-09 NL NL7301863A patent/NL7301863A/xx unknown
- 1973-02-16 PH PH14350*A patent/PH10214A/en unknown
- 1973-02-19 IE IE252/73A patent/IE37292B1/xx unknown
- 1973-02-23 BE BE795828D patent/BE795828A/xx unknown
- 1973-02-23 GB GB905473A patent/GB1356097A/en not_active Expired
- 1973-02-23 AT AT163273A patent/AT322744B/de not_active IP Right Cessation
- 1973-02-23 JP JP48021406A patent/JPS4896717A/ja active Pending
- 1973-02-23 CA CA164,470A patent/CA1023990A/en not_active Expired
- 1973-02-23 FR FR7306517A patent/FR2173263B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU451930B2 (en) | 1974-08-22 |
| AT322744B (de) | 1975-06-10 |
| PH10214A (en) | 1976-09-29 |
| IE37292L (en) | 1973-08-25 |
| BE795828A (fr) | 1973-08-23 |
| IL41412A0 (en) | 1973-03-30 |
| FR2173263A1 (enrdf_load_html_response) | 1973-10-05 |
| FR2173263B1 (enrdf_load_html_response) | 1975-10-10 |
| CA1023990A (en) | 1978-01-10 |
| IT978459B (it) | 1974-09-20 |
| GB1356097A (en) | 1974-06-12 |
| DE2305980A1 (de) | 1973-08-30 |
| ZA73467B (en) | 1973-10-31 |
| AU5145573A (en) | 1974-07-25 |
| JPS4896717A (enrdf_load_html_response) | 1973-12-10 |
| NL7301863A (enrdf_load_html_response) | 1973-08-28 |
| IL41412A (en) | 1976-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2000045770A3 (en) | Compressed lecithin preparations | |
| IE37292L (en) | Mineral salt preparation | |
| IE881916L (en) | Press-coated dihydropyridine tablets | |
| IL76138A (en) | Pharmaceutical formulation in the form of sucralfate suspension and its preparation | |
| IE45655L (en) | Gastric reflux treatment composition | |
| ES430431A1 (es) | Varistor de oxido metalico. | |
| ATE75941T1 (de) | Pulvrige, hydrophile theophyllinformulierung und verfahren zu ihrer herstellung. | |
| EP0237241A3 (en) | Calcium supplement compressed tablets | |
| GB1298494A (en) | Phenylethanolamine derivatives | |
| ES8600051A1 (es) | Procedimiento de obtencion de composiciones farmaceuticas a base de derivados de acido glicirretinico. | |
| AU528098B2 (en) | Analgesic tablet | |
| JP2001527022A5 (enrdf_load_html_response) | ||
| GB1464200A (en) | Pharmaceutical composition | |
| ES8705763A1 (es) | Procedimiento para preparar nuevas formulaciones de gel parafines terapeuticos y diagnosticos | |
| GB1191246A (en) | Vitamin-containing Preparations | |
| JPS57152858A (en) | Acesulfam containing composition and production thereof | |
| GB1403900A (en) | Pharmaceutical composition | |
| GB1355985A (en) | Solid slow release preparation of prolonged action | |
| IE34077L (en) | Dentifrice compositions | |
| EP0377119A1 (en) | Agent for reducing adverse effects of table salt | |
| Matsumoto et al. | Mechanism of material deformation related to shape and crown phenomena | |
| JPS646214A (en) | Remedy for ulcerative colonopathy | |
| IE34386B1 (en) | Pharmaceutical compositions | |
| MY107599A (en) | Sucralfate suspension compounds. | |
| ES472528A1 (es) | Procedimiento para la preparacion de derivados de benzosul- fonamida |